In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Transforming Cancer Drug Development Via Artificial Intelligence

Executive Summary

Using a simulation-based drug discovery platform, Turbine is dramatically reshaping drug discovery and development, explains CEO and co-founder Szabolcs Nagy, a 2021 Rising Leader.

You may also be interested in...



Finance Watch: $1.32bn In New Biopharma VC Financings As Year-End Approaches

Private Company Edition: In recent weeks, 19 companies disclosed venture capital funding of $20m or more, including FogPharma with a $178m series D round and Apogee’s $169m launch. Also, Avalon BioVentures spun out of Avalon Ventures with a $135m fund.

Leading By Example: A Starting Point To Address Disparities In Health Care

As the head of inclusive investments and partnerships lead for Publicis Health Media, Karima Sharif’s expertise in media and strategy has led to the development of rich relationships. She oversees partnerships with more than 600 firms, ranging from lifestyle groups – such as NBC – to endemic HCP partners, such as the New England Journal of Medicine and WebMD

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

IV124868

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel